Low and high levels of hormone in men with heart failure associated with increased risk of death
Men with systolic chronic heart failure who have low
or high levels of estradiol, a form of the hormone estrogen, have an increased
risk of death compared with men with moderate levels of this hormone, according
to a study in the May 13 issue of JAMA.
Estrogens have numerous biological effects in men and
have a complex effect on the normal cardiovascular system, including cardioprotective
effects, which may explain the link between low estradiol concentrations and an
increased risk of cardiovascular events in men, according to background information
in the article.
Ewa A. Jankowska, M.D., Ph.D., of the Center for Heart
Disease, Military Hospital, Wroclaw, Poland, and colleagues examined the relationship
between estradiol concentrations in the blood and the rate of death in men with
chronic heart failure (HF) and reduced left ventricular ejection fraction (LVEF).
The study, conducted at two cardiology centers in Poland, included 501 men (average
age, 58 years). The patients were divided into 5 groups (quintiles), determined
by the level of estradiol in their blood. Quintile 3 was considered the reference
group.
Among the patients, 171 deaths (34 percent) occurred
during the 3-year follow-up. Analysis indicated that the most favorable outcome
was in patients with estradiol levels within the middle quintile, whereas the
highest 3-year mortality rates were observed in men in the lowest quintile (about
4 times higher risk of death) and those in the highest quintile (about twice the
risk of death) of circulating estradiol levels.
For increasing estradiol quintiles, 3-year survival rates
adjusted for clinical variables and androgens (male sex hormones) were: 44.6 percent
for quintile 1; 65.8 percent for quintile 2; 82.4 percent for quintile 3; 79.0
percent for quintile 4; and 63.6 percent for quintile 5.
"Both low and high concentrations of circulating estradiol
are significant predictors of a poor prognosis, independently of gonadal and adrenal
androgen deficiencies and conventional clinical prognostic indicators," the authors
write. "Further studies are needed to explain the origin of these hormonal derangements."
|